Periodic Reporting for period 1 - ONCODESTROYER (Targeting cancer vulnerabilities in acute leukemia)

The overall objective of the action (ONCODESTROYER) is to evaluate the therapeutic potential of a new class of anti-cancer drugs in acute myeloid leukemia (AML), using clinical study samples and mouse models. Acute myeloid leukemia (AML) is a relatively infrequent cancer, yet...